Heart Diseases Summit 2019

Previous Speakers

Ingolf Schimke

Director Berlin Cures GmbH Germany

Sayed Mohsen Hosseini

Professor Isfahan University of Medical Sciences Iran

Janos Magyar

Head of Division of Sport Physiology University of Debrecen Hungary

Ala Ashour

Faculty of Nursing at Hashemite University Jordan

Yin Kang

MD PhD Fuwai Hospital China

Srinivasa Kumaran

MGR medical university India

Deepak Puri

Executive Director and Head Cardiac Sciences Cardiomersion India

Mohammad Abdul Matin

Cardiologist Bangladesh

Recommended Global Cardiology Conferences

About Conference

After the splendid success of “2^nd World Heart Congress” held at Tokyo, Japan during May 14-16, 2018 we proudly announce the "4^th Global Summit on Heart Diseases" which will be held during March 15-16, 2019 at Singapore.

Heart Diseases Summit 2019 will gather world-class teachers, scientists and cardiologists to discuss methodology for ailment remediation for heart, Electrocardiography, Heart Failure, Nuclear Cardiology conferences, cardiology meetings are planned to give varying and stream preparing that will keep helpful specialists next to each other of the issues impacting the expectation, finding and treatment of cardiovascular contamination. The assembling will be dealt with around the subject “The Future of Cardiology: Research on Diagnosis & Treatment Techniques for Cardiac Diseases".

Conference Series llc LTD deals with a meeting course of action of 1000+ Global Events thorough of 300+Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia with sponsorship from 1000 more sensible social requests and disseminates 700+ Open get to journals which contains more than 30000 unmistakable personalities, reputed specialists as article board people.

Why to go???

With people from around the world focused on getting some answers concerning Heart Diseases, this is your single most obvious opportunity to accomplish the greatest accumulation of individuals from the mending focuses, Universities, bunch, etc. This Heart Diseases Summit in 2019 will coordinate appears, disperse information, meet with recurring pattern and potential investigators and get name affirmation at this 2-day event. Broadly acclaimed speakers, the most recent frameworks, methodologies, and the most current updates in Cardiology field are indications of this conference.

Target Audience:

Cardiologists

Cardiac Surgeons

Cardiology Students, Scientists

Cardiology Researchers

Cardiology Faculty

Medical Colleges

Cardiology Associations and Societies members

Business Entrepreneurs

Training Institutes

Manufacturing Medical Devices Companies

Benefits:

Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations)
Get participation certificate from Heart Diseases Summit 2018 Organising Committee Members
You can make contacts with eminent keynote speakers and research professionals for your career growth.
Get 5 star hospitality at the conference venue
B 2 B Meeting with the Companies
Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations)
Full Conference Kit with Conference Souvenir and Final Program (e-copies)
Abstracts will be published in the conference souvenir and respective International journals
Each Abstract will receive unique (DOI) Number provided by Cross Ref
Group Registration benefits

Sessions/ Tracks

Conference Series llc LTD invites all the participants from all over the world to attend the “4^th Global Summit on Heart Diseases” during March 15-16, 2019 at Singapore which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Track 1: Heart Diseases & Heart failure

Heart Disease is a major cause of disability and premature death throughout the world. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, generally in middle age. Acute coronary events (heart attacks) and cerebrovascular events (strokes) frequently occur suddenly, and are often fatal before medical care can be given. Heart Conferences promotes awareness against Risk factor modification which reduces clinical events and premature death in people with established cardiovascular disease as well as in those who are at high cardiovascular risk due to one or more risk factors.

Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently. Not all conditions that lead to heart failure can be reversed, but treatments can improve the signs and symptoms of heart failure and help you live longer. Lifestyle changes such as exercising, reducing salt in your diet, managing stress and losing weight can improve your quality of life.

One way to prevent heart failure is to control conditions that cause heart failure, such as coronary artery disease, high blood pressure, diabetes or obesity.

Related Conferences

4^th International Conference on Hypertension & Healthcare September 10-11, 2018. Amsterdam, Netherlands; 4^thWorld Heart Congress, April 29-May 1, 2019, Kyoto Japan; Global Cardiology Summit, August 15-16,2018, Tokyo, Japan; International Conference on Cardiovascular Imaging, November 19-21,2018,Melbourne,Australia. 6^th World Heart Failure Congress, June 21- 24, 2018, Azerbaijan: Cardiovascular Innovations July 26-18, 2018 USA; 12^thAustralian and New Zealand Endovascular Therapies Annual Meeting August 3-5, 2018 Australia; Pediatric and Adult Congenital Cardiology Review Course, August 19-14, 2018 USA; Transcatheter Cardiovascular TherapeuticsSeptember 21-25, 2018 USA

Related Societies: American Heart Association Dallas, USA, North America ; Cardiology Society Los Angeles, USA, North America; Emirates Cardiac Society Macau, Hong Kong ; Japanese Circulation Society, Japan; British Junior Cardiologists Association London, UK; Cardiac Society of Australia and New Zealand Sydney, Australia; World Society of Arrhythmias Beijing, China; Philippine Heart Association Manila, Philippines; Asian Society for Cardiovascular Surgery (ASCVS) Fukuoka, Japan, Asia ; The Pan-African Society of Cardiology (PASCAR) Algeria, Africa ; Iranian Heart Foundation Iran ; Emirates Cardiac Society Macau, Hong Kong ; Saudi Heart Association Riyadh, Saudi Arabia ; Gulf Heart Association Macau, Hong Kong ; Indonesian Heart Association, Indonesia.

Track 2: Heart Diagnosis & Devices

Medical diagnosis is based on information from sources such as findings from a physical examination, interview with the patient or family or both, medical history of the patient and family, and clinical findings as reported by laboratory tests and radiologic studies. The diagnosis of heart can be carried out by various methods such as by Imaging techniques, Surgeries, electrophysiology, angiography, radiography etc. Medical care is very essential once the heart disease is diagnosed. The aim of treatment are stabilizing the condition, controlling symptoms over the long term, and providing a cure when possible. Stress reduction, diet, and lifestyle changes are key in managing heart disease, but the main stays of conventional care are drugs and surgery.

Heart Devices are electronic devices for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The evolution of these wireless cardiac monitoring devices is marking a new era in medicine and a transition from population-level health care to individualized medicine in which suitable patients are equipped with advanced biosensors that, in turn, have their data processed through sophisticated algorithms to predict events before they occur. The pacemaker, defibrillators, biosensors are the heart devices used in treatment of heart diseases.

Related Conferences

International Conference on Cardiovascular Imaging, November 19-21,2018,Melbourne,Australia. 6^th World Heart Failure Congress, June 21- 24, 2018, Azerbaijan: Cardiovascular Innovations July 26-18, 2018 USA; 12^th Australian and New Zealand Endovascular Therapies Annual Meeting August 3-5, 2018 Australia; Pediatric and Adult Congenital Cardiology Review Course, August 19-14, 2018 USA; Transcatheter Cardiovascular Therapeutics September 21-25, 2018 USA; 4^th International Conference on Hypertension & Healthcare September 10-11, 2018. Amsterdam, Netherlands; 4^thWorld Heart Congress, April 29-May 1, 2019, Kyoto Japan; Global Cardiology Summit, August 15-16,2018, Tokyo, Japan

Track 3: Cardiac Nursing and Healthcare

Cardiac nursing is a registered nurse who specializes to work with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help to treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses also perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centres, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.

Related Conferences

Track 4: Pediatric & Geriatric Cardiology

Pediatric Cardiology concern all aspects of heart disease in infants, children, and adolescents, including embryology and anatomy, physiology and pharmacology, biochemistry, pathology, genetics, radiology, clinical aspects, investigative cardiology, electrophysiology and echocardiography, and cardiac surgery. Pediatric Cardiology is responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations and electrophysiology studies. The increasing number of neonates with congenital heart defects referred to the neonatal intensive care unit reflects the increasing awareness that the defects may be present. Chest radiography and ECG rarely assist in the neonatal diagnosis.

Related Conferences

Track 5: Cardiovascular Surgeries

Cardiac surgery will be surgery on the heart performed by cardiac surgeons. Every now and again, it is done to treat inconveniences of ischemic coronary illness, amend inherent coronary illness, or treat valvular coronary illness from different causes including endocarditis, rheumatic coronary illness and atherosclerosis. It also includes heart transplantation. The advancement of cardiac surgery and cardiopulmonary bypass techniques has diminished the mortality rates of these surgeries to generally low positions. For instance, repairs of are currently assessed to have 4–6% death rates.

Related Conferences

Track 6: Cardiologists

A cardiologist is a doctor who specializes in the studies of heart & its functions & also diagnosis, treatment and preventing diseases related to heart and blood vessels. You might also visit a cardiologist so you can learn about your risk factors for heart disease and find out what measures you can take for better heart health. Cardiology is a field which is changing rapidly, New technologies as drug-eluting stents, assist devices for left ventricle, and novel inflammatory markers, and imaging modalities such as magnetic resonance imaging and 3D echocardiography.

Related Conferences

Track 7: Cardiovascular Toxicology and Pharmacology

Cardiovascular pharmacology focuses on the fundamental mechanisms of cardiovascular cells and how drugs influence the heart and vascular system and those parts of the nervous and endocrine systems that participate in regulating cardiovascular function. Researchers observe the effects of drugs on arterial pressure, blood flow in specific vascular beds, release of physiological mediators, and neural activity arising from central nervous systemstructures.

Cardiovascular toxicology is concerned with the adverse effects of extrinsic and intrinsic stresses on the heart and vascular system. Extrinsic stress involves exposure to therapeutic drugs, natural products, and environmental toxicants. Intrinsic stress refers to exposure to toxic metabolites derived from nontoxic compounds such as those found in food additives and supplements. The intrinsic exposures also include secondary neurohormonal disturbance such as overproduction of inflammatory cytokines derived from pressure overload of the heart and counter-regulatory responses to hypertension. These toxic exposures result in alterations in biochemical pathways, defects in cellular structure and function, and pathogenesis of the affected cardiovascular system.

Related Conferences

Track 8: Cardio-Oncology

Cardio-oncology is the intersection of heart conditions in patients who have been treated for cancer. New insights into how cancer therapies impact cardiovascular homeostasis and long-term effects on cancer survivors. In view of trends, as well as the cardiovascular toxicity potential of radiation and chemotherapy, cancer patients are exposed to cardiovascular morbidity and mortality more than ever before. Anticancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure (HF), independently from the direct myocardial or pericardial damage that might occur. Moreover, cancer is generally associated with a hypercoagulable state, which increases the risk of acute thrombotic events.

Related Conferences

Track 9: Heart and Obesity

People with a body mass index (BMI) of 30 or higher are considered obese. The term obesity is used to describe the health condition of anyone significantly above his or her ideal healthy weight. Obesity increases the risk for heart disease and stroke. But it harms more than just the heart and blood vessel system. It's also a major cause of gallstones, osteoarthritis and respiratory problems. Obesity is intimately intertwined with multiple health conditions that underlie cardiovascular disease including high blood pressure, diabetes, and abnormal blood cholesterol. In addition, weight gain is a frequent consequence of heart-damaging lifestyle choices such as lack of exercise and a fat-laden diet. Obesity also can lead to heart failure. This is a serious condition in which your heart can't pump enough blood to meet your body's needs

Related Conferences

Track 10: Clinical Cardiology

Cardiology concerns with diseases and disorders of the heart, such as coronary artery disease and congestive heart failure. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, vascular heart disease and electrophysiology. Although the heart and circulatory system make up your cardiovascular system. Heart works as a pump that pushes blood to the organs, tissues, and cells of your body. Blood delivers oxygen and nutrients to every cell and removes the carbon dioxide and waste products made by those cells.

Related Conferences

Track 11: Cardiac Regeneration

Cardiac Regeneration is a broad effort and comes into existence when the cardiac tissue is damaged and failed to regenerate the myocardium. Where the main principle behind cardiac regeneration is Reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. Reparative tools have been engineered to restore damaged heart tissue and function using the body's natural ability to regenerate. Current therapies includes such as adult stem and precursor cells, Nuclear dynamics of the heart growth, Reprogramming Fibroblasts to Cardiomyocytes, Stem cells and cell therapy.

Related Conferences

Track 12: Cardiovascular Engineering

Cardiovascular Engineering stimulates innovative methods and technological advancements in the basic understanding of the cardiovascular system and in cardiovascular diagnosis and treatment applications. Original Contributions outline new concepts and applications in cardiovascular mechanics, cardiology applications and diagnostic methods, cardiac and vascular imaging, devices and instrumentation, hemodynamic monitoring and measurements, cardiac assistance, vascular grafts and artificial hearts, cardiac electrophysiology techniques, computer modeling and drug delivery systems.

Related Conferences

Track 13: Nuclear Cardiology & Cardiac CT

Heart disease is the leading cause of death in the western world. Each year in the U.S.A, more than 500,000 men and women die from coronary artery disease. During the past two decades, major strides have been made in the diagnosis and treatment of heart disease. Nuclear Cardiology has played a pivotal role in establishing the diagnosis of heart disease and in the assessment of disease extent and the prediction of outcomes in the setting of coronary artery disease. Nuclear cardiology studies use noninvasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most widely used.

A cardiac CT scan is a painless imaging test that uses x rays to take many detailed pictures of your heart and its blood vessels. Different CT scanners are used for different purposes. A multi detector CT is a very fast type of CT scanner that can produce high-quality pictures of the beating heart and can detect calcium or blockages in the coronary arteries. An electron beam CT scanner also can show calcium in coronary arteries. The information obtained can help evaluate whether you are at increased risk for heart attack.

Related Conferences

Track 14: Molecular Cardiology and Hypertension

Molecular cardiology is a new area of cardiovascular medicine that aims to apply molecular biological techniques for the mechanistic investigation, diagnosis, prevention, and treatment of cardiovascular disease. As an emerging discipline, it has changed our conceptual thinking of cardiovascular development, disease etiology, and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. A great interest of the laboratory is the identification of novel circulating factors that regulate cardiac biology, including aging and hypertrophy.

Hypertension is the single most important risk factor for stroke. It causes about 50 per cent of ischemic strokes and also increases the risk of hemorrhagic stroke. The damage that hypertension causes happens over time and is often only diagnosed when considerable damage has already happened to the body’s blood vessels. The increase in cardiovascular risk has primarily been described in terms of elevated systolic pressure in those over age 60 years and elevation in diastolic pressure in younger individuals.

Related Conferences

Track 15: Vascular Heart Disease

Vascular heart disease is characterized by damage to or a defect in one of the four heart valves: the mitral, aortic, tricuspid or pulmonary. In vascular heart disease, the valves become too narrow and hardened (stenosis) to open fully, or are unable to close completely (incompetent). Valve disease symptoms can occur suddenly, depending upon how quickly the disease develops. Many of the symptoms are similar to those associated with congestive heart failure, such as shortness of breath and wheezing after limited physical exertion and swelling of the feet, ankles, hands or abdomen (edema). The severity of vascular heart disease varies. In mild cases there may be no symptoms, while in advanced cases, vascular heart disease may lead to congestive heart failure and other complications. Treatment depends upon the extent of the disease.

Related Conferences

Track 16: Myocardial and Pericardial Disease

Damage to the heart muscle most often develops from coronary artery disease (CAD) related myocardial infarction, usually in people in their middle or later decades. Inherited forms of heart muscle disease (Cardiomyopathies) are the most prominent cause of myocardial disease in the young. Myocardial infarction and cardiomyopathies are the major causes of heart failure and arrhythmic sudden death.

Pericardial disease or pericarditis is an inflammation of the pericardium. Pericarditis is characterised by pericardial friction rub (an audible sound of rubbing heard along with the heart beat), chest pain and changes in an electrocardiogram (ECG, test to evaluate the heart function). It is seen more commonly in men than in women. Chronic pericarditis may occur due to the recurrence of acute pericarditis or due to a chronic infection such as tuberculosis.

Related Conferences

Track 17: Paediatric Cardiology

Pediatric Cardiology is responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations, and electrophysiology studies, and for the ongoing management of the sequelae of heart disease in infants, children and adolescents.

Related Conferences

Track 18: Arrhythmias

An arrhythmia is a problem with the rate or rhythm heartbeat. It means that heart beats too quickly, too slowly, or with an irregular pattern. Many factors can affect heart's rhythm, such as having had a heart attack, smoking, congenital heart defects, and stress. Some substances or medicines may also cause arrhythmias. There are four main types of arrhythmia: extra beats, supraventricular tachycardias, ventricular arrhythmias, and brady arrhythmias Most arrhythmias can be effectively treated. Treatments may include medications, medical procedures such as a pacemaker, and surgery. Medications for a fast heart rate may include beta blockers or agents that attempt to restore a normal heart rhythm such as procainamide.

Related Conferences

Track 19: Critical Cardiac Care

Critical cardiac care (CIC) which is also known as coronary care unit (CCU) is a hospital ward specialized in the care of patients with heart attacks, unstable angina, cardiac dysrhythmia and (in practice) various other cardiac conditions that require continuous monitoring and treatment or first aid treatment till the doctor comes. There are also units available in the hospitals to take care of the emergency situation. The Cardiac intensive care unit (CICU) is a specialized ICU dealing with cardiac patients and is usually staffed by cardiologists. It offers critical care staff especially trained in acute coronary syndromes and has additional technology such as intra-aortic balloon pumps, etc.

Related Conferences

Track 20: Cardiovascular Diseases and Nutrition

The Cardiovascular diseases affecting the developed world have at their core atherosclerosis and hypertension, both of which are profoundly affected by diet and can be approached, at least in part, from a nutritional point of view, as can the increasing “epidemic” of obesity. Diet is a multi-component mixture of many nutrients, which may interact with one another. The definitive study of nutrients and their impact on cardiovascular disease can be a daunting enterprise. Many dietary risk factors contribute to these diseases in various environmental and ethnic settings. These risk factors are often in evidence in youth so that preventive measures must be initiated early in life.

Related Conferences

Market Analysis

Scope and Importance:

A prospective survey of patients with valscular heart disease (VHD):

Coronary angiography was used in 85.2% of patients before intervention.
The Euro Heart Survey (EHS) programme has been initiated in order to provide quantitative information on cardiovascular disease.
To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease, and to develop appropriate models for healthy CV lifestyle.

Greatest Achievements in the Field of Cardiology:

Electrocardiography
Cardiac catheterization
Coronary angiography
Cardiovascular surgery
Invasive cardiology
The coronary care unit
Cardiovascular drugs
Preventive cardiology
Echocardiography
Pacemakers and internal defibrillators

Market Value of Cardiology Research:-

Cardiac surgery is on the advance worldwide, includes, Arrhythmia Treatment, Heart Valve Repair or Replacement, Coronary Artery Bypass Grafting, Aneurysm Repair, Trans myocardial Laser Revascularization, Surgery to Place Ventricular Assist Devices and heart transplant.

U.S contributes 46% of world share in Cardiovascular Surgery devices. The global cardiology surgical & interventional cardiology devices market is may grow at the CAGR of 8%, and will contributes $83128.34 billion till 2022. The real ascent in the global cardiology surgical & interventional cardiology devices market is due to the increased prevalence of life style oriented diseases among the aging population. The global cardiology surgical & interventional cardiology devices market is divided into North America, Europe, Asia Pacific and Rest of the World. Among all, North America is the leader of the market having 46%of market shares, followed by Europe. North America is dominating country due to high prevalence of cardiovascular diseases & various technological advancements. Europe is the second major shareholder with 27% of market share in global cardiology surgical & interventional cardiology devices market. Asia pacific is the fastest growing market in this field due to increasing population & rapid development process. India & China are the major contributors in APAC region & are expected to fuel this market further.

Market Growth of Cardiology Research in the last and upcoming years:

The global cardiac device industry is growing rapidly and exhibits signs that it will continue to evolve and expand to reach over $97 billion by 2017, up from nearly $85 billion in 2010 according to a study from BCC Research.

Medical Products manufactured by the industry related to Heart Diseases research globally:-

Pacemakers

Implantable defibrillators Stents

Remote Patient Management

Vascular/Surgical Devices

Small Molecules

Heart valve corrective device

Stents

Specialized medicines

Medical Diagnostic Instruments

Single-use cardiovascular medical devices

Fund allotment by Organizations:-

Worldwide Funding’s:-

21ST CENTURY THERAPEUTICS , INC. :- $335,740

3-C INSTITUTE FOR SOCIAL DEVELOPMENT :- $1,142,420

ABREOS BIOSCIENCES, INC. :- $6,453,446

AARON DIAMOND AIDS RESEARCH CENTER: - $439,428

1646 organizations gives funds for Cardiology research Worldwide.

Total funding by Organizations:- $13,99,59,15,573

For More Information: Please Click here

Top-Ranked Hospitals for Heart Diseases & Cardiology:

Globally:

Cleveland Clinic, Ohio

Mayo Clinic, Rochester

New York-Presbyterian University Hospital of Columbia and Cornell, New York

Duke University Hospital, Durham

Brigham and Women's Hospital, Boston

Massachusetts General Hospital, Boston

Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia

Cedars-Sinai Medical Center, Los Angeles

St Francis Hospital, Roslyn, New York

Mount Sinai Hospital, New York

Associations and Societies:-

Worldwide:-

The American Heart Association

Heart Failure Society of America

American Association of Heart Failure Nurses (AAHFN)

Association for European Paediatric Cardiology

European Society of Cardiology

Heart Valve Society of America (HVSA)

International Society for Heart Research (ISHR)

Working Group for Cardiac Magnetic Resonance Spanish Society of Cardiology

Society of Invasive Cardiovascular Professionals

Industries Globally for cardiology Research:

Sanofi

AstraZeneca

GlaxoSmithKline

Care stream Health

Intelomed

Keystone Medical Technologies

List of Universities:-

Worldwide:-

University of Oxford

Harvard University

Stanford University

Yale University

Duke University

Columbia University

Imperial College London

University of Sydney

University of Basel

New York University (NYU)

Past Conference Report

Heart Congress 2018

2^nd World Heart Congress was hosted by the Conference Series LLC at Tokyo, Japan during May 14- 16, 2018 with the theme “A Changed Outlook in Cardiology and Healthcare”.

The conference marked its start by an opening ceremony which included introduction by the Honorable Guests and the Members of Keynote Forum. All the speakers have extended their contribution in the form of highly informative presentations to lead the conference to the ladder of success.

Conference Series extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.

We would like to specially thank the following people who laid the foundation for the event’s success.

Organizing Committee Members:

Damien Byas- Center for Healthcare and Organizational Research, USA
Aris Lacis- Children’s Clinical University Hospital, Latvia
Carola Y Förster- University of Wurzburg, Germany
Mary Shibuya - Gunma University, Japan
Michiaki Nagai- Hiroshima City Asa Hospital, Japan
Galya Atanasova- Medical University Pleven, Bulgaria
Satoru Takeno – Kindai University School of Medicine, Japan
Beder Gustavo Farez –Italia Clinic in San Luis, Argentina

Keynote Speakers:

Damien Byas- Center for Healthcare and Organizational Research, USA
Aris Lacis- Children’s Clinical University Hospital, Latvia
Jacob Ostrowsky- Rainbow Babies & Children’s Hospital, USA
Marc-Alexander Ohlow- Zentralklinik Bad Berka, GermanyUniversity, Japan
Ashish K Saxena- Diabetes and Heart Centre, India
Gad Keren- Tel Aviv Medical Center, Israel
Galya Atanasova Medical University Pleven, Bulgaria

Moderator:

Mary Shibuya - Gunma University, Japan

After the huge optimistic response from scientific fraternity, renowned personalities and the Editorial Board Members of Conference Series from across the world. We are pleased to announce the 4^th Global Summit on Heart Diseases to be held during March 15-16, 2019 at Singapore.

Past Reports Gallery